Notice of Intent to Re-Issue a Funding Opportunity Announcement (FOA) Rare Diseases Clinical Research Consortia (RDCRC) for Rare Diseases Clinical Research Network (U54)
Notice NOT-TR-18-002 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - November 7, 2017 Category: Research Source Type: funding
Notice of Intent to Re-Issue a Funding Opportunity Announcement (FOA) Data Management and Coordinating Center (DMCC) for Rare Diseases Clinical Research Network (RDCRN) (U01)
Notice NOT-TR-18-003 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - November 7, 2017 Category: Research Source Type: funding
Palliative Care Needs of Individuals with Rare Advanced Diseases and Their Family Caregivers (R21 Clinical Trial Optional)
Funding Opportunity PA-18-167 from the NIH Guide for Grants and Contracts. This funding opportunity announcement (FOA) seeks to expand knowledge and increase the evidence base for palliative care (PC) in advanced rare diseases, including rare cancers, and to improve physical and psychosocial well-being and quality of life among seriously ill individuals and their family caregivers. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - November 7, 2017 Category: Research Source Type: funding
Palliative Care Needs of Individuals with Advanced Rare Diseases and Their Family Caregivers (R01 Clinical Trial Optional)
Funding Opportunity PA-18-149 from the NIH Guide for Grants and Contracts. This funding opportunity announcement (FOA) seeks to expand knowledge and increase the evidence base for palliative care (PC) in advanced rare diseases, including rare cancers, and to improve physical and psychosocial well-being and quality of life among seriously ill individuals and their family caregivers. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - November 7, 2017 Category: Research Source Type: funding
Notice of Change to Expiration Date in NOT-TR-17-019 "Request for Information (RFI): Opportunities and Challenges for Platform Vector Human Gene Therapy Trials in Rare Diseases"
Notice NOT-TR-17-024 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 18, 2017 Category: Research Source Type: funding
Request for Information: Opportunities and Challenges for Platform Vector Human Gene Therapy Trials in Rare Diseases
Notice NOT-TR-17-019 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - July 18, 2017 Category: Research Source Type: funding
Small Business Innovation Research on Rare Musculoskeletal, Rheumatic and Skin Diseases (SBIR) (R43)
Funding Opportunity RFA-AR-18-005 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) solicits Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) that propose preclinical studies to advance the development of biomarkers or treatments for rare musculoskeletal, rheumatic or skin diseases. Rare diseases have a prevalence of fewer than 200,000 affected individuals in the United States. Also eligible for potential funding through this initiative are studies of FDA-designated orphan products for musculoskeletal, rheumatic or skin diseases. (Sou...
Source: NIH Funding Opportunities (Notices, PA, RFA) - April 11, 2017 Category: Research Source Type: funding
Notice of NICHD's Participation in PA-16-183 "Limited Competition: Rare Diseases Clinical Research Network (RDCRN) Project Supplements for Clinical Trials to Repurpose Drugs in Collaboration with E-Rare Awardees (Admin Supp)"
Notice NOT-HD-16-016 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - June 30, 2016 Category: Research Source Type: funding
Notice of NINDS' Participation in PA-16-183 "Limited Competition: Rare Diseases Clinical Research Network (RDCRN) Project Supplements for Clinical Trials to Repurpose Drugs in Collaboration with E-Rare Awardees (Admin Supp)"
Notice NOT-NS-16-030 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - June 1, 2016 Category: Research Source Type: funding
Notice of National Heart, Lung, and Blood Institute (NHLBI) Participation in PA-16-183 "Limited Competition: Rare Diseases Clinical Research Network (RDCRN) Project Supplements for Clinical Trials to Repurpose Drugs in Collaboration with E-Rare Awardees"
Notice NOT-HL-16-322 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - May 24, 2016 Category: Research Source Type: funding
Notice of NIAID's Participation in PA-16-183 "Limited Competition: Rare Diseases Clinical Research Network (RDCRN) Project Supplements for Clinical Trials to Repurpose Drugs in Collaboration with E-Rare Awardees (Admin Supp)"
Notice NOT-AI-16-052 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - May 16, 2016 Category: Research Source Type: funding
Small Market Awards: SBIR Phase IIB Competing Renewals for Heart, Lung, Blood, and Sleep Technologies with Small Commercial Markets (R44)
Funding Opportunity Number: RFA-HL-17-012 Opportunity Category: DiscretionaryFunding Instrument Type: GrantCategory of Funding Activity: HealthCFDA Number: 93.23393.35093.83793.83893.83993.840Eligible Applicants Small businessesAgency Name: HHS-NIH11Closing Date: Jun 20, 2018Award Ceiling: $3,000,000Expected Number of Awards: Creation Date: Apr 18, 2016Funding Opportunity Description: The purpose of the NHLBI SBIR Phase IIB Small Market Award is to provide support to Phase II SBIR or STTR awardees developing NHLBI mission-related technologies that address a rare disease or young pe...
Source: Grants.gov - April 19, 2016 Category: Research Tags: Health Source Type: funding
Small Market Awards: SBIR Phase IIB Competing Renewals for Heart, Lung, Blood, and Sleep Technologies with Small Commercial Markets (R44)
Funding Opportunity RFA-HL-17-012 from the NIH Guide for Grants and Contracts. The purpose of the NHLBI SBIR Phase IIB Small Market Award is to provide support to Phase II SBIR or STTR awardees developing NHLBI mission-related technologies that address a rare disease or young pediatric populations. The goal of this FOA is for these technologies to be further validated so that development can continue with private funding after NHLBI support ends. Applicants must submit a Commercialization Plan that includes details on any independent third-party funding that has already been secured or is anticipated during the proje...
Source: NIH Funding Opportunities (Notices, PA, RFA) - April 18, 2016 Category: Research Source Type: funding
Natural History Studies for Rare Disease Product Development: Orphan Products Research Project Grant (R01)
The objective of FDA's Orphan Products Natural History Grants Program is to support studies that advance rare disease medical product development through characterization of the natural history of rare diseases/conditions, identification of genotypic and phenotypic subpopulations, and development and/or validation of clinical outcome measures, biomarkers and/or companion diagnostics. The ultimate goal of these natural history studies is to support clinical development of products for use in rare diseases or conditions where no current therapy exists or where the proposed product will be superior to the existing therapy. FD...
Source: Grants.gov - April 16, 2016 Category: Research Tags: Health Source Type: funding
Limited Competition: Rare Diseases Clinical Research Network (RDCRN) Project Supplements for Clinical Trials to Repurpose Drugs in Collaboration with E-Rare Awardees (Admin Supp)
Funding Opportunity Number: PA-16-183 Opportunity Category: DiscretionaryFunding Instrument Type: GrantCategory of Funding Activity: Food and NutritionHealthCFDA Number: 93.35093.84693.847Eligible Applicants State governmentsCounty governmentsCity or township governmentsSpecial district governmentsIndependent school districtsPublic and State controlled institutions of higher educationNative American tribal governments (Federally recognized)Public housing authorities/Indian housing authoritiesNative American tribal organizations (other than Federally recognized tribal governments)Nonprofits having a 5...
Source: Grants.gov - April 13, 2016 Category: Research Tags: Food and Nutrition Health Source Type: funding
